MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arai, A. C.
Right arrow Articles by Lynch, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arai, A. C.
Right arrow Articles by Lynch, G.

Vol. 62, Issue 3, 566-577, September 2002

Effects of 5'-Alkyl-Benzothiadiazides on (R,S)-alpha -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Biophysics and Synaptic Responses

Amy C. Arai, Yan-Fang Xia, Markus Kessler, Dean Phillips, Richard Chamberlin, Richard Granger, and Gary Lynch

Department of Pharmacology (A.C.A., Y.-F.X., M.K.), Southern Illinois University School of Medicine, Springfield, Illinois; and Departments of Psychiatry (R.G., G.L.) and Chemistry (D.P., R.C.), University of California, Irvine, California

Alkyl-substituted benzothiadiazides (BTDs) were tested for their effects on (R,S)-alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors. In excised patches, the 5'-ethyl derivative "D1" blocked the desensitization of AMPA receptor currents during prolonged application of glutamate (EC50, 36 µM), and it slowed deactivation of responses elicited by 1-ms glutamate pulses greater than 10-fold. [3H]Fluorowillardiine binding to rat synaptic membranes was increased by D1 by a factor of 3.6 (EC50, 17 µM) with a Hill coefficient near 2. In hippocampal slices, the compound reversibly increased excitatory postsynaptic currents and field excitatory postsynaptic potentials (EPSPs) with thresholds around 10 µM. The size of the alkyl substituent influenced both the potency and nature of the drug effect on synaptic currents: 5'-methyl compounds had a 2-fold greater effect on response amplitude than on response duration, whereas 5'-ethyl compounds like D1 caused greater increases in duration than amplitude. In tests with recombinantly expressed AMPA receptor subunits, D1 preferred the glutamate receptor (GluR) subunit GluR4 flip (0.64 µM) over GluR4 flop (5.3 µM); similar affinities but with smaller flip-flop differences were obtained for GluR1 through 3. These results show that D1 and congeners are significantly more potent than the parent compound IDRA-21 and that they differ in two fundamental aspects from cyclothiazide, the most widely studied BTD: 1) D1 markedly increases the agonist affinity of AMPA receptors and 2) it has immediate and large effects on field EPSPs. The large gain in potency conferred by alkyl substitution suggests that the 5' substituent is in intimate contact with the receptor, with the size of the substituent determining the way in which receptor kinetics is changed.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. Jourdi, X. Lu, T. Yanagihara, J. C. Lauterborn, X. Bi, C. M. Gall, and M. Baudry
Prolonged Positive Modulation of {alpha}-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Induces Calpain-Mediated PSD-95/Dlg/ZO-1 Protein Degradation and AMPA Receptor Down-Regulation in Cultured Hippocampal Slices
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 16 - 26.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Suzuki, M. Kessler, K. Montgomery, and A. C. Arai
Divergent Effects of the Purinoceptor Antagonists Suramin and Pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on {alpha}-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors
Mol. Pharmacol., December 1, 2004; 66(6): 1738 - 1747.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. D. Leever, S. Clark, A. M. Weeks, and K. M. Partin
Identification of a Site in GluR1 and GluR2 That Is Important for Modulation of Deactivation and Desensitization
Mol. Pharmacol., July 1, 2003; 64(1): 5 - 10.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. C. Arai, Y.-F. Xia, G. Rogers, G. Lynch, and M. Kessler
Benzamide-Type AMPA Receptor Modulators Form Two Subfamilies with Distinct Modes of Action
J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1075 - 1085.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics